Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review

Research

BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1936 (Published 26 May 2020) Cite this as: BMJ 2020;369:m1936

Read our latest coverage of the coronavirus pandemic

Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study
- Abstract
- Fulltext
- PDF
Heterogeneity and temporal variation in the management of COVID-19: a multinational drug utilization study including 71,921 hospitalized patients from China, South Korea, Spain, and the United States of America
- Abstract
- Fulltext
- PDF
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials
- Abstract
- Fulltext
- PDF
From SARS and MERS to COVID-19: a review of the quality and responsiveness of clinical management guidelines in outbreak settings
- Abstract
- Fulltext
- PDF
Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial
- Abstract
- Fulltext
- PDF
Effect of Dexamethasone in Hospitalized Patients with COVID-19 - Preliminary Report
- Abstract
- Fulltext
- PDF
Recommendations for SARS-CoV-2/COVID-19 testing: a scoping review of current guidance
- Abstract
- Fulltext
- PDF
Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm
- Abstract
- Fulltext
- PDF
Rashford, racism, and bankrupt excuses
- Abstract
- Fulltext
- PDF